ENTITY
Sanofi India

Sanofi India (SANL IN)

29
Analysis
Health Care • India
Sanofi India Limited manufactures pharmaceuticals and chemicals. The Company has a worldwide presence, an extensive portfolio of prescription medicines, a portfolio of vaccines, major biological products, generics medicines, consumer healthcare, animal healthcare, and has a presence in both traditional and emerging markets.
more
bullish•Indegene
•02 May 2024 11:27

Indegene Pre-IPO - RHP Updates - Client Base Continued to Grow, and Margins Have Begun Stabilizing

Indegene Limited (1864095D IN) is looking to raise about US$220m in its upcoming India IPO. We looked at the firm’s past performance in an earlier...

Logo
820 Views
Share
bullish•Mankind Pharma
•25 Mar 2024 21:42

Mankind Pharma Placement - Well Flagged, past Deals Have Done Well but Its Expensive

ChrysCap is looking to raise around US$295m via selling a 2.8% stake in Mankind Pharma. In this note, we talk about the deal dynamics.

Logo
419 Views
Share
bullish•Mankind Pharma
•12 Dec 2023 09:58

Mankind Pharma Placement - Its Expensive, but at Least It’s High Quality

A group of shareholders is looking to raise around US$600m via selling a 6.9% stake in Mankind Pharma. We had looked at the lockup release earlier.

Logo
639 Views
Share
bullish•Mankind Pharma
•08 May 2023 12:45

Mankind Pharma IPO Trading - Strong Insti Demand Makes up for Retail Lag

Mankind Pharma  raised around US$527m in its upcoming India IPO. In this note, we talk about the demand updates and the trading dynamics.

Logo
502 Views
Share
bullish•Mankind Pharma
•19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
572 Views
Share
x